FARALLON CAPITAL MANAGEMENT LLC
Q4 2019 13F-HR Holdings
Net value change ($000)
+12,463,847
(743222.8%)
New positions
100
Sold out positions
3
Turnover %
100.0%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q3 2019
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| MTCH | 514,786 | NEW |
| FIS | 484,834 | NEW |
| WAB | 394,383 | NEW |
| ELV | 377,538 | NEW |
| GOOGL | 367,551 | NEW |
| MSFT | 344,699 | NEW |
| CHTR | 331,355 | NEW |
| CI | 306,735 | NEW |
| IQV | 286,568 | NEW |
| V | 286,070 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| Allergan plc | -1,049 | -100.0% |
| WELLCARE HEALTH PLANS, INC. | -614 | -100.0% |
| MELLANOX TECHNOLOGIES LTD | -14 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
1,838,644
(14.7% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|